STAT4 and COL1A2 are potential diagnostic biomarkers and therapeutic targets for heart failure comorbided with

Kai Huang1, Xinying Zhang2, Jiahao Duan1

  • 1Department of Cardiology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.

Insights

Heart failure (HF) and depression share underlying mechanisms. Bioinformatics analysis identified STAT4 and COL1A2 as key genes, offering potential therapeutic targets for this common comorbidity.

Area of Science:

  • Biomedical Informatics
  • Cardiovascular Research
  • Psychiatric Genetics

Background:

  • Heart failure (HF) and depression frequently co-occur, significantly impacting patient quality of life and societal costs.
  • The precise biological mechanisms driving this comorbidity remain incompletely understood.
  • Existing evidence suggests a strong link, necessitating further investigation into shared pathological pathways.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying the comorbidity of heart failure and depression.
  • To identify potential diagnostic biomarkers and therapeutic targets for co-occurring HF and depression.
  • To leverage bioinformatics network analysis for uncovering shared genetic and pathway associations.

Main Methods:

  • Downloaded Gene Expression Omnibus (GEO) datasets for HF and depression.
  • Constructed co-expression networks using Weighted Gene Co-Expression Network Analysis (WGCNA).
  • Performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.
  • Built a protein-protein interaction (PPI) network using the STRING database to identify hub genes.
  • Validated hub gene expression in additional HF and depression datasets.

Main Results:

  • Functional enrichment analysis implicated platelet activation, chemokine signaling, and focal adhesion pathways.
  • Protein-protein interaction network analysis identified five key hub genes: STAT4, CD83, CX3CR1, COL1A2, and SH2D1B.
  • Validation datasets confirmed the significant involvement of STAT4 and COL1A2 in the HF-depression comorbidity.

Conclusions:

  • Identified five hub genes (STAT4, CD83, CX3CR1, COL1A2, SH2D1B) associated with HF and depression comorbidity.
  • STAT4 and COL1A2 were highlighted as particularly crucial in the underlying mechanisms of this dual diagnosis.
  • These findings suggest shared pathways that may serve as novel targets for future research into the pathogenesis and treatment of comorbid HF and depression.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
243
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
57
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
82
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
67